Search results
Results from the WOW.Com Content Network
Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and ...
In 2018, Amneal Pharmaceuticals LLC merged with Impax Laboratories, Inc. to form Amneal Pharmaceuticals, Inc. Shares of newly public AMRX began trading on the NYSE on May 7, 2018. [9] Concurrent with the Impax merger, Amneal acquired Gemini Laboratories for $117 million, including Unithroid, Gemini's lead product for treating hypothyroidism. [10]
The 10-second takeawayFor the quarter ended June 30 (Q2), Impax Laboratories beat expectations on revenues and crushed expectations on earnings Impax Laboratories Crushes Earnings Estimates Skip ...
Impax Laboratories Reports First Quarter 2013 Results HAYWARD, Calif.--(BUSINESS WIRE)-- Impax Laboratories, Inc. today reported first quarter 2013 adjusted net income of $25.3 million or $0.37 ...
Impax Laboratories Announces Reduction in Workforce HAYWARD, Calif.--(BUSINESS WIRE)-- Impax Laboratories, Inc. (NAS: IPXL) today announced a reduction in its workforce as a part of the Company ...
The 10-second takeawayFor the quarter ended March 31 (Q1), Impax Laboratories whiffed on revenues and beat expectations on earnings per share. Impax Laboratories Beats Analyst Estimates on EPS ...
Impax Laboratories to Present at the Piper Jaffray 24 th Annual Healthcare Conference HAYWARD, Calif.--(BUSINESS WIRE)-- Impax Laboratories, Inc. today announced that the Company will present at ...
Impax Laboratories (NAS: IPXL) reported earnings on May 1. Here are the numbers you need to know. The 10-second takeaway For the quarter ended March 31 (Q1), Impax Laboratories beat expectations ...